Louisiana State University Health Sciences Center
New Orleans, Louisiana
| drug abuse|| pain|
| opioids|| cannabinoids|
Opioid analgesics are currently the primary treatment for chronic pain. However, therapeutic doses have several untoward side effects, including tolerance to the analgesic effects and physical dependence. Our laboratory has identified that co-administration of a cannabinoid agonist with an opioid can increase the analgesic effect, thus reducing the required dose. My projects in the France laboratory are exploring the therapeutic potential of these opioid-cannabinoid combinations. A primary goal of the research is to characterize the development of tolerance and dependence during chronic administration of opioid-cannabinoid combinations in an assay of analgesia.
Accomplishments, Awards and Honors
NRSA Postdoctoral Training Fellow (T32) - UTHSCSA - 2015